Valence Life Sciences

CalciMedica, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, specializing in the discovery and development of small molecule drugs aimed at treating autoimmune and inflammatory diseases. Founded in December 2006 by a team of scientists with backgrounds in the field, the company focuses on the specific inhibition of calcium release-activated calcium channels. This innovative approach seeks to modulate the immune response and protect against tissue cell injury, addressing significant unmet medical needs in life-threatening inflammatory conditions for which existing therapies are lacking. CalciMedica's proprietary technology has the potential to offer therapeutic benefits in these challenging areas of healthcare.

CalciMedica, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, specializing in the discovery and development of small molecule drugs aimed at treating autoimmune and inflammatory diseases. Founded in December 2006 by a team of scientists with backgrounds in the field, the company focuses on the specific inhibition of calcium release-activated calcium channels. This innovative approach seeks to modulate the immune response and protect against tissue cell injury, addressing significant unmet medical needs in life-threatening inflammatory conditions for which existing therapies are lacking. CalciMedica's proprietary technology has the potential to offer therapeutic benefits in these challenging areas of healthcare.

JenaValve Technology, Inc. is a medical device company specializing in the design, development, and manufacturing of transcatheter aortic valve replacement (TAVR) systems for patients with severe aortic regurgitation and aortic stenosis. Founded in 2006 and headquartered in Irvine, California, with additional locations in Munich, Germany, and Leeds, United Kingdom, the company focuses on providing innovative solutions for high-risk patients who may not be suitable candidates for traditional surgical aortic valve replacement. The company's flagship product, the Trilogy™ Heart Valve System, received CE Mark approval in May 2021 and is notable for its dual-disease treatment capabilities. JenaValve's TAVR systems feature a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame, designed to engage with the native valve structures for optimal performance. The company has also received Breakthrough Device Designation from the U.S. Food and Drug Administration to facilitate the review of its pivotal trial for the Trilogy Heart Valve System in the United States.

Invuity, Inc. is a medical technology company based in San Francisco, California, specializing in the development and marketing of surgical devices designed for enhanced visualization during minimally invasive procedures. Founded in 2004, the company utilizes advanced photonics technology to create illuminated surgical devices that provide surgeons with improved illumination and direct visualization of surgical cavities. Its product offerings include various illuminated retractor systems and handheld illuminators suitable for multiple surgical specialties, such as orthopedics, gynecology, and plastic surgery. Notable products include the Eikon LT illuminated retractor system, the PhotonBlade illuminator, and the BriteField Port System, all designed to enhance precision, efficiency, and safety during surgical procedures. Invuity sells its devices through a combination of direct sales representatives, independent agents, and directly to hospitals and surgeons. The company was previously known as Spotlight Surgical, Inc. and adopted its current name in 2007. As of 2018, Invuity operates as a subsidiary of Stryker Corporation.

Invuity, Inc. is a medical technology company based in San Francisco, California, specializing in the development and marketing of surgical devices designed for enhanced visualization during minimally invasive procedures. Founded in 2004, the company utilizes advanced photonics technology to create illuminated surgical devices that provide surgeons with improved illumination and direct visualization of surgical cavities. Its product offerings include various illuminated retractor systems and handheld illuminators suitable for multiple surgical specialties, such as orthopedics, gynecology, and plastic surgery. Notable products include the Eikon LT illuminated retractor system, the PhotonBlade illuminator, and the BriteField Port System, all designed to enhance precision, efficiency, and safety during surgical procedures. Invuity sells its devices through a combination of direct sales representatives, independent agents, and directly to hospitals and surgeons. The company was previously known as Spotlight Surgical, Inc. and adopted its current name in 2007. As of 2018, Invuity operates as a subsidiary of Stryker Corporation.

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company designs and evaluates optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Notable products in its pipeline include VYXEOS, a nano-scale liposomal formulation of irinotecan and floxuridine, and CPX-351, a liposomal formulation of cytarabine and daunorubicin, both in Phase III clinical trials for acute myeloid leukemia. Additionally, CPX-1, a liposomal formulation of irinotecan and floxuridine, has completed Phase II studies for colorectal cancer. Celator also has a preclinical candidate, CPX-8, which is a hydrophobic docetaxel prodrug nanoparticle formulation. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

Invuity, Inc. is a medical technology company based in San Francisco, California, specializing in the development and marketing of surgical devices designed for enhanced visualization during minimally invasive procedures. Founded in 2004, the company utilizes advanced photonics technology to create illuminated surgical devices that provide surgeons with improved illumination and direct visualization of surgical cavities. Its product offerings include various illuminated retractor systems and handheld illuminators suitable for multiple surgical specialties, such as orthopedics, gynecology, and plastic surgery. Notable products include the Eikon LT illuminated retractor system, the PhotonBlade illuminator, and the BriteField Port System, all designed to enhance precision, efficiency, and safety during surgical procedures. Invuity sells its devices through a combination of direct sales representatives, independent agents, and directly to hospitals and surgeons. The company was previously known as Spotlight Surgical, Inc. and adopted its current name in 2007. As of 2018, Invuity operates as a subsidiary of Stryker Corporation.

Invuity, Inc. is a medical technology company based in San Francisco, California, specializing in the development and marketing of surgical devices designed for enhanced visualization during minimally invasive procedures. Founded in 2004, the company utilizes advanced photonics technology to create illuminated surgical devices that provide surgeons with improved illumination and direct visualization of surgical cavities. Its product offerings include various illuminated retractor systems and handheld illuminators suitable for multiple surgical specialties, such as orthopedics, gynecology, and plastic surgery. Notable products include the Eikon LT illuminated retractor system, the PhotonBlade illuminator, and the BriteField Port System, all designed to enhance precision, efficiency, and safety during surgical procedures. Invuity sells its devices through a combination of direct sales representatives, independent agents, and directly to hospitals and surgeons. The company was previously known as Spotlight Surgical, Inc. and adopted its current name in 2007. As of 2018, Invuity operates as a subsidiary of Stryker Corporation.